These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37384868)

  • 1. Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
    Wadensten E; Wessman S; Abel F; Diaz De Ståhl T; Tesi B; Orsmark Pietras C; Arvidsson L; Taylan F; Fransson S; Vogt H; Poluha A; Pradhananga S; Hellberg M; Lagerstedt-Robinson K; Raj Somarajan P; Samuelsson S; Orrsjö S; Maqbool K; Henning K; Strid T; Ek T; Fagman H; Olsson Bontell T; Martinsson T; Puls F; Kogner P; Wirta V; Pronk CJ; Wille J; Rosenquist R; Nistér M; Mertens F; Sabel M; Norén-Nyström U; Grillner P; Nordgren A; Ljungman G; Sandgren J; Gisselsson D;
    JCO Precis Oncol; 2023 Jun; 7():e2300039. PubMed ID: 37384868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.
    Chang W; Brohl AS; Patidar R; Sindiri S; Shern JF; Wei JS; Song YK; Yohe ME; Gryder B; Zhang S; Calzone KA; Shivaprasad N; Wen X; Badgett TC; Miettinen M; Hartman KR; League-Pascual JC; Trahair TN; Widemann BC; Merchant MS; Kaplan RN; Lin JC; Khan J
    Clin Cancer Res; 2016 Aug; 22(15):3810-20. PubMed ID: 26994145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
    Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
    PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
    Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
    BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.
    Newman S; Nakitandwe J; Kesserwan CA; Azzato EM; Wheeler DA; Rusch M; Shurtleff S; Hedges DJ; Hamilton KV; Foy SG; Edmonson MN; Thrasher A; Bahrami A; Orr BA; Klco JM; Gu J; Harrison LW; Wang L; Clay MR; Ouma A; Silkov A; Liu Y; Zhang Z; Liu Y; Brady SW; Zhou X; Chang TC; Pande M; Davis E; Becksfort J; Patel A; Wilkinson MR; Rahbarinia D; Kubal M; Maciaszek JL; Pastor V; Knight J; Gout AM; Wang J; Gu Z; Mullighan CG; McGee RB; Quinn EA; Nuccio R; Mostafavi R; Gerhardt EL; Taylor LM; Valdez JM; Hines-Dowell SJ; Pappo AS; Robinson G; Johnson LM; Pui CH; Ellison DW; Downing JR; Zhang J; Nichols KE
    Cancer Discov; 2021 Dec; 11(12):3008-3027. PubMed ID: 34301788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
    Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC; Fangusaro JR; Mitchell SG; Pauly MG; Pencheva B; Wechsler DS; Graham DK; Goldsmith KC
    JCO Precis Oncol; 2022 Apr; 6():e2100451. PubMed ID: 35544730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
    Parsons DW; Roy A; Yang Y; Wang T; Scollon S; Bergstrom K; Kerstein RA; Gutierrez S; Petersen AK; Bavle A; Lin FY; López-Terrada DH; Monzon FA; Hicks MJ; Eldin KW; Quintanilla NM; Adesina AM; Mohila CA; Whitehead W; Jea A; Vasudevan SA; Nuchtern JG; Ramamurthy U; McGuire AL; Hilsenbeck SG; Reid JG; Muzny DM; Wheeler DA; Berg SL; Chintagumpala MM; Eng CM; Gibbs RA; Plon SE
    JAMA Oncol; 2016 May; 2(5):616-624. PubMed ID: 26822237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.
    Marks LJ; Oberg JA; Pendrick D; Sireci AN; Glasser C; Coval C; Zylber RJ; Chung WK; Pang J; Turk AT; Hsiao SJ; Mansukhani MM; Glade Bender JL; Kung AL; Sulis ML
    Front Pediatr; 2017; 5():265. PubMed ID: 29312904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
    Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
    Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
    Mody RJ; Wu YM; Lonigro RJ; Cao X; Roychowdhury S; Vats P; Frank KM; Prensner JR; Asangani I; Palanisamy N; Dillman JR; Rabah RM; Kunju LP; Everett J; Raymond VM; Ning Y; Su F; Wang R; Stoffel EM; Innis JW; Roberts JS; Robertson PL; Yanik G; Chamdin A; Connelly JA; Choi S; Harris AC; Kitko C; Rao RJ; Levine JE; Castle VP; Hutchinson RJ; Talpaz M; Robinson DR; Chinnaiyan AM
    JAMA; 2015 Sep; 314(9):913-25. PubMed ID: 26325560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-seq Fusion Detection in Clinical Oncology.
    Hedges DJ
    Adv Exp Med Biol; 2022; 1361():163-175. PubMed ID: 35230688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing.
    Hehir-Kwa JY; Koudijs MJ; Verwiel ETP; Kester LA; van Tuil M; Strengman E; Buijs A; Kranendonk MEG; Hiemcke-Jiwa LS; de Haas V; van de Geer E; de Leng W; van der Lugt J; Lijnzaad P; Holstege FCP; Kemmeren P; Tops BBJ
    JCO Precis Oncol; 2022 Jan; 6():e2000504. PubMed ID: 35085008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric CNS cancer genomics and immunogenomics.
    Miller KE; Mardis ER
    Curr Opin Genet Dev; 2022 Aug; 75():101918. PubMed ID: 35617766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.
    Heipertz AE; Pajtler KW; Pfaff E; Schramm K; Blattner-Johnson M; Milde T; Jones BC; Zuliani C; Hutter C; Lohi O; Kattamis A; Dachowska-Kalwak I; Nilsson A; Gerber NU; Langenberg KPS; Goemans B; Zwaan CM; Molenaar JJ; Jäger N; Dirksen U; Witt R; Pfister SM; Jones DTW; Kopp-Schneider A; Witt O; van Tilburg CM
    JCO Precis Oncol; 2023 Jun; 7():e2300015. PubMed ID: 37364231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.